CD 34 Cell Dose is Associated with Less Relapse after Matched but Not Haploidentical Stem Cell Transplantation

Authors :: Neal Flomenberg
Joanne Filicko-O'Hara
Ubaldo Martinez
Thomas R. Klumpp
Sameh Gaballa
Dolores Grosso
Margaret Kasner
Neil Palmisiano
William O'Hara
Pierluigi Porcu
Michael Sun
Matthew Carabasi
Onder Alpdogan
Source :: Biology of Blood and Marrow Transplantation. 24:S330-S331
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Transplantation
Oncology
medicine.medical_specialty
Cell dose
business.industry
Internal medicine
medicine
Hematology
Stem cell
business

Full Text Access

Tools